Voltar
Artigo Revisado por pares
BIBTEX RIS

Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer

2025; Massachusetts Medical Society; Volume: 392; Issue: 6 Linguagem: Inglês

10.1056/nejmoa2405008

ISSN

1533-4406

Autores

Alison M. Schram, Kōichi Goto, Dong-Wan Kim, Teresa Macarulla, Antoine Hollebecque, Eileen M. O’Reilly, Sai‐Hong Ignatius Ou, Jordi Rodón, Sun Young Rha, Kazumi Nishino, M. Duruisseaux, Joon Oh Park, Cindy Neuzillet, Stephen V. Liu, Benjamin A. Weinberg, James M. Cleary, Emiliano Calvo, Kumiko Umemoto, Misako Nagasaka, Christoph Springfeld, Tanios Bekaii‐Saab, Grainne M. O’Kane, Frans L. Opdam, Kim A. Reiss, Andrew K. Joe, Ernesto Wasserman, Viktoriya Stalbovskaya, Jim Ford, Shola Adeyemi, Lokesh Jain, Shekeab Jauhari, Alexander Drilon,

Tópico(s)

Pancreatic and Hepatic Oncology Research

Referência(s)